Showing 2891-2900 of 5663 results for "".
Evaluating the Interleukin Antibodies and Their Future in Psoriasis Therapy
https://practicaldermatology.com/topics/psoriasis/PD0809_13-php/22791/New investigational therapies blocking IL-12/23 may offer new possibilities in the treatment of psoriatic disease.Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0709_04-php/22799/A User's Guide to the Field of Biologic Therapies
https://practicaldermatology.com/topics/psoriasis/PD0709_01-php/22796/All the facts you need to know about available biologic therapies, assembled in one place.Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0509_05-php/22827/Inflamed Feelings: The Psychological Effects of Inflammatory Disorders
https://practicaldermatology.com/topics/psoriasis/PD0309_05-php/22859/Data suggest that children and adults suffering from chronic inflammatory skin diseases, such as eczema and psoriasis, are at higher risk for depression, anxiety, and other psychiatric illnesses.Who's Responsible for Your Receivables?
https://practicaldermatology.com/topics/general-topics/PD0109_02-php/22889/When it comes to timely collection of payments, different staff members have important responsibilities.Characterizing “Obese Skin”: Aesthetic Considerations Following GLP-1-Induced Rapid Weight Loss
https://practicaldermatology.com/topics/cosmetic/characterizing-obese-skin/24565/Characterizing “Obese Skin”: Aesthetic Considerations Following GLP-1-Induced Rapid Weight LossWebsite Rankings of Dermatology Associations; News and Trends
https://practicaldermatology.com/youngmd-connect/resident-resource-center/website-rankings-of-dermatology-associations-news-and-trends/20854/Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
https://practicaldermatology.com/programs/cme/test-your-skills-and-learn-from-experts-on-il-13-inhibitors-in-moderate-to-severe-atopic-dermatitis/37624/Watch an expert-led case discussion on the role of IL-13 in moderate to severe atopic dermatitis and the efficacy on its inhibition through biologic therapies to achieve control.Continuity of Psoriasis Care in the Era of COVID-19
https://practicaldermatology.com/columns/clinical-focus-1/continuity-of-psoriasis-care-in-the-era-of-covid-19/23285/While there’s no data about susceptibility to COVID-19 in psoriasis, there is relevant information on infectious complications from biologics.